Travere Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Core Viewpoint - Travere Therapeutics, Inc. will present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026, at 4:30 p.m. PT, highlighting its ongoing commitment to engaging with investors and stakeholders in the healthcare sector [1]. Company Information - Eric Dube, Ph.D., serves as the president and chief executive officer of Travere Therapeutics [1]. - A live webcast of the presentation will be available on the Investor page of Travere's website, with a replay accessible for up to 30 days post-event [1].